Genentech Oncology
From healthcare providers and society members to administrators–we all play important roles in advancing patient care. See how these resources may help support you and your oncology patients.
Explore this Genentech report, which highlights key trends across the healthcare industry–from staffing, capacity, and burnout to digital health delivery and care inequity.
Review the Genentech Healthcare Disparities 2022 Insights Report. It encourages conversations that address the needs of populations that have been underserved for too long.
Learn about Genentech Patient Support Services, which helps patients after a Genentech medicine has been prescribed, including understanding insurance coverage, access and affordability options.
Use this white paper when considering program components for minimizing patients’ cost burden. Published by Genentech in collaboration with the Cleveland Clinic Cancer Institute (CCCI), it shares key learnings from CCCI’s patient-focused model for addressing access issues related to financial toxicity.
*This collaboration was identified by Genentech and the Cleveland Clinic as a shared effort to share information about successful processes that lead to reduced financial burden for patients. The piece was co-authored by members of the Cleveland Clinic and Genentech teams. There was no financial exchange between the two organizations.
Genentech has resources available to raise awareness about screening and early cancer detection. These materials are available in multiple languages to meet the education needs of different populations. Find resources that may be helpful for your patients and communities.
Download and print this flashcard for an emotional reminder for Black and Hispanic women about how much they mean to their loved ones. (Available in English and Spanish)
Display this poster to share a real letter and a moving message about the importance of regular cancer screening for Black and Hispanic women. (Available in English and Spanish)
Genentech is a founding funder of this national initiative convened by the American Cancer Society (ACS). Share this ACS site with your providers and patients to learn more and access resources, including screening recommendations and a screening locator tool.
Explore this site to find useful screening resources for providers, insurers, employers, patients and communities.
Share these videos with patients to help them better understand clinical research.
Share these videos with patients to help them make better-informed decisions about clinical study participation.
Explore this site to find educational resources, guidelines, and related coverage information on biomarker testing for healthcare professionals.
Expert-led educational videos on biomarker testing are available to empower your patients to learn more and take control of their NSCLC diagnosis.
These videos are independently developed by A Breath of Hope Lung Foundation. Genentech does not control and is in no way responsible for the content.
As a member organization of the American Cancer Society, Genentech is pleased to share these resources from the American Cancer Society for use as needed by your organization. These resources provide an overview of the services for patients exclusively administered by ACS, including:
Please note that free services, including lodging and transportation assistance programs, are independently administered by the American Cancer Society. Genentech does not control and is not responsible for the execution of the programs.
4R is a care sequence tool that puts people with cancer in the driver’s seat, empowering them to help plan and manage their care.
Access the 4R Oncology Care Coordination tool here.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.